Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Mayo Clinic Laboratories Mayo Clinic United States | 182 | 117 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 163 | 110 |
|
Bcell/Antibody Deficiency GenePanel Mayo Clinic Laboratories Mayo Clinic United States | 79 | 61 |
|
Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Mendelian Susceptibility to Mycobacterial Disease Panel PreventionGenetics, part of Exact Sciences United States | 29 | 17 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Incontinentia pigmenti, 308300, X-linked dominant; IP (Incontinentia pigmenti) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Congenital Diarrhea and Enteropathies Panel PreventionGenetics, part of Exact Sciences United States | 241 | 157 |
|
Anterior Segment Dysgenesis Disorders Panel PreventionGenetics, part of Exact Sciences United States | 272 | 278 |
|
X-Linked Intellectual Disability Panel PreventionGenetics, part of Exact Sciences United States | 191 | 141 |
|
Incontinentia Pigmenti Common Deletion Analysis (Prenatal Diagnosis) Baylor Genetics United States | 4 | 1 |
|
Incontinentia Pigmenti Common Deletion Analysis Baylor Genetics United States | 4 | 1 |
|
X-chromosome High Resolution microarray analysis Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 240 | 171 |
|
Molecular Vision Laboratory United States | 1 | 1 |
|
Baylor Genetics United States | 1 | 1 |
|
IKBKG Sequence Analysis (Targeted Analysis) Baylor Genetics United States | 1 | 1 |
|
IKBKG Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 1 | 1 |
|
Incontinentia Pigmenti: gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Syndromes with immunodeficiency Panel CeGaT GmbH Germany | 33 | 38 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.